Previous Article | Next Article 
Journal of Clinical Microbiology, January 1999, p. 141-145, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Influence of Incubation Time, Inoculum Size, and
Glucose Concentrations on Spectrophotometric Endpoint Determinations
for Amphotericin B, Fluconazole, and Itraconazole
M. Hong
Nguyen* and
Christine Y.
Yu
Department of Medicine, University of Florida
College of Medicine, and Gainesville VA Medical Center,
Gainesville, Florida
Received 24 April 1998/Returned for modification 30 June
1998/Accepted 15 October 1998
We addressed the influence of the incubation time (24 h versus
48 h), starting inoculum size (standard inoculum size,
~103 CFU/ml, versus large inoculum size,
~104 CFU/ml), and supplementation with 2% glucose of
RPMI 1640 medium on the spectrophotometric determination of the MICs of
amphotericin B, fluconazole, and itraconazole. We compared the MICs
determined spectrophotometrically with those determined by the standard
broth macrodilution method (National Committee for Clinical Laboratory Standards approved guideline M27-A). The agreement between the results
of the spectrophotometric and standard methods for amphotericin B
testing was 100%; this agreement was independent of the inoculum size
and incubation time. On the other hand, the agreement for the results
for fluconazole testing and itraconazole testing was dependent on the
inoculum size and incubation time. With large inoculum size, excellent
agreement can be achieved at 24 h. With standard inoculum size,
acceptable agreement can be achieved only at 48 h. In contrast to
previous observations, the addition of 2% glucose did not have any
significant impact on the growth density at 24 h, nor did it
improve the agreement with the standard method. Furthermore,
supplemental glucose might falsely elevate the MIC at 48 h.
*
Corresponding author. Mailing address: University of
Florida College of Medicine, Department of Medicine, Section of
Infectious Diseases, P.O. Box 100277, JHMHC, Gainesville, FL 32610. Phone: (352) 379-4027. Fax: (352) 379-4015. E-mail:
nguyemt{at}medicine.ufl.edu.
Journal of Clinical Microbiology, January 1999, p. 141-145, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Pfaller, M. A., Diekema, D. J., Procop, G. W., Rinaldi, M. G.
(2007). Multicenter Comparison of the VITEK 2 Antifungal Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Amphotericin B, Flucytosine, and Voriconazole against Candida spp.. J. Clin. Microbiol.
45: 3522-3528
[Abstract]
[Full Text]
-
Perumal, P., Mekala, S., Chaffin, W. L.
(2007). Role for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms. Antimicrob. Agents Chemother.
51: 2454-2463
[Abstract]
[Full Text]
-
Espinel-Ingroff, A., Barchiesi, F., Cuenca-Estrella, M., Fothergill, A., Pfaller, M. A., Rinaldi, M., Rodriguez-Tudela, J. L., Verweij, P. E.
(2005). Comparison of Visual 24-Hour and Spectrophotometric 48-Hour MICs to CLSI Reference Microdilution MICs of Fluconazole, Itraconazole, Posaconazole, and Voriconazole for Candida spp.: a Collaborative Study. J. Clin. Microbiol.
43: 4535-4540
[Abstract]
[Full Text]
-
Cocuaud, C., Rodier, M.-H., Daniault, G., Imbert, C.
(2005). Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother
56: 507-512
[Abstract]
[Full Text]
-
Espinel-Ingroff, A., Barchiesi, F., Cuenca-Estrella, M., Pfaller, M. A., Rinaldi, M., Rodriguez-Tudela, J. L., Verweij, P. E.
(2005). International and Multicenter Comparison of EUCAST and CLSI M27-A2 Broth Microdilution Methods for Testing Susceptibilities of Candida spp. to Fluconazole, Itraconazole, Posaconazole, and Voriconazole. J. Clin. Microbiol.
43: 3884-3889
[Abstract]
[Full Text]
-
Gomez-Lopez, A., Aberkane, A., Petrikkou, E., Mellado, E., Rodriguez-Tudela, J. L., Cuenca-Estrella, M.
(2005). Analysis of the Influence of Tween Concentration, Inoculum Size, Assay Medium, and Reading Time on Susceptibility Testing of Aspergillus spp.. J. Clin. Microbiol.
43: 1251-1255
[Abstract]
[Full Text]
-
Dannaoui, E., Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Verweij, P. E., the Eurofung Network,
(2003). In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother
51: 45-52
[Abstract]
[Full Text]
-
Liao, R. S., Rennie, R. P., Talbot, J. A.
(2002). Comparative Evaluation of a New Fluorescent Carboxyfluorescein Diacetate-Modified Microdilution Method for Antifungal Susceptibility Testing of Candida albicans Isolates. Antimicrob. Agents Chemother.
46: 3236-3242
[Abstract]
[Full Text]
-
Arthington-Skaggs, B. A., Lee-Yang, W., Ciblak, M. A., Frade, J. P., Brandt, M. E., Hajjeh, R. A., Harrison, L. H., Sofair, A. N., Warnock, a. D. W.
(2002). Comparison of Visual and Spectrophotometric Methods of Broth Microdilution MIC End Point Determination and Evaluation of a Sterol Quantitation Method for In Vitro Susceptibility Testing of Fluconazole and Itraconazole against Trailing and Nontrailing Candida Isolates. Antimicrob. Agents Chemother.
46: 2477-2481
[Abstract]
[Full Text]
-
Espinel-Ingroff, A., Bartlett, M., Chaturvedi, V., Ghannoum, M., Hazen, K. C., Pfaller, M. A., Rinaldi, M., Walsh, T. J.
(2001). Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation. Antimicrob. Agents Chemother.
45: 1828-1835
[Abstract]
[Full Text]
-
St-Germain, G., Laverdière, M., Pelletier, R., Bourgault, A.-M., Libman, M., Lemieux, C., Noël, G.
(2001). Prevalence and Antifungal Susceptibility of 442 Candida Isolates from Blood and Other Normally Sterile Sites: Results of a 2-Year (1996 to 1998) Multicenter Surveillance Study in Quebec, Canada. J. Clin. Microbiol.
39: 949-953
[Abstract]
[Full Text]
-
Cuenca-Estrella, M., Díaz-Guerra, T. M., Mellado, E., Rodríguez-Tudela, J. L.
(2001). Influence of Glucose Supplementation and Inoculum Size on Growth Kinetics and Antifungal Susceptibility Testing of Candida spp.. J. Clin. Microbiol.
39: 525-532
[Abstract]
[Full Text]